+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Antithrombotic Drugs Market 2023-2027

  • PDF Icon

    Report

  • 156 Pages
  • May 2023
  • Region: Global
  • TechNavio
  • ID: 5835924
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The antithrombotic drugs market is forecasted to grow by USD 23,199.94 mn during 2022-2027, accelerating at a CAGR of 8.42% during the forecast period. The report on the antithrombotic drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of coagulation disorders, the introduction of novel oral anticoagulants, and a strong r and d pipeline in building.

The antithrombotic drugs market is segmented as below:

By Route of Administration

  • Oral
  • Injectable

By Distribution Channel

  • Hospital pharmacy
  • Retail pharmacy
  • Online pharmacy

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the advent of anticoagulant antidotes as one of the prime reasons driving the antithrombotic drugs market growth during the next few years. Also, strategic partnerships and acquisitions of companies in market focus and growing new developments in market focus will lead to sizable demand in the market.

The report on the antithrombotic drugs market covers the following areas:

  • Antithrombotic drugs market sizing
  • Antithrombotic drugs market forecast
  • Antithrombotic drugs market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antithrombotic drugs market vendors that include AbbVie Inc., Aspen Pharmacare Holdings Ltd, AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Fresenius Kabi AG. Also, the antithrombotic drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global antithrombotic drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global antithrombotic drugs market 2017 - 2021 ($ million)
4.2 Route of Administration Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Route of Administration
6.1 Market segments
Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%)
6.2 Comparison by Route of Administration
Exhibit 32: Chart on Comparison by Route of Administration
Exhibit 33: Data Table on Comparison by Route of Administration
6.3 Oral - Market size and forecast 2022-2027
Exhibit 34: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Oral - Year-over-year growth 2022-2027 (%)
6.4 Injectable - Market size and forecast 2022-2027
Exhibit 38: Chart on Injectable - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Injectable - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Injectable - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Injectable - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Route of Administration
Exhibit 42: Market opportunity by Route of Administration ($ million)
Exhibit 43: Data Table on Market opportunity by Route of Administration ($ million)
7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 46: Chart on Comparison by Distribution Channel
Exhibit 47: Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacy - Market size and forecast 2022-2027
Exhibit 48: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
7.4 Retail pharmacy - Market size and forecast 2022-2027
Exhibit 52: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
7.5 Online pharmacy - Market size and forecast 2022-2027
Exhibit 56: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 60: Market opportunity by Distribution Channel ($ million)
Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Japan - Market size and forecast 2022-2027
Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Aspen Pharmacare Holdings Ltd
Exhibit 111: Aspen Pharmacare Holdings Ltd - Overview
Exhibit 112: Aspen Pharmacare Holdings Ltd - Business segments
Exhibit 113: Aspen Pharmacare Holdings Ltd - Key offerings
Exhibit 114: Aspen Pharmacare Holdings Ltd - Segment focus
12.4 AstraZeneca PLC
Exhibit 115: AstraZeneca PLC - Overview
Exhibit 116: AstraZeneca PLC - Product/Service
Exhibit 117: AstraZeneca PLC - Key news
Exhibit 118: AstraZeneca PLC - Key offerings
12.5 Bayer AG
Exhibit 119: Bayer AG - Overview
Exhibit 120: Bayer AG - Business segments
Exhibit 121: Bayer AG - Key news
Exhibit 122: Bayer AG - Key offerings
Exhibit 123: Bayer AG - Segment focus
12.6 Boehringer Ingelheim International GmbH
Exhibit 124: Boehringer Ingelheim International GmbH - Overview
Exhibit 125: Boehringer Ingelheim International GmbH - Business segments
Exhibit 126: Boehringer Ingelheim International GmbH - Key news
Exhibit 127: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 128: Boehringer Ingelheim International GmbH - Segment focus
12.7 Bristol Myers Squibb Co.
Exhibit 129: Bristol Myers Squibb Co. - Overview
Exhibit 130: Bristol Myers Squibb Co. - Product/Service
Exhibit 131: Bristol Myers Squibb Co. - Key news
Exhibit 132: Bristol Myers Squibb Co. - Key offerings
12.8 Daiichi Sankyo Co. Ltd.
Exhibit 133: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 134: Daiichi Sankyo Co. Ltd. - Product/Service
Exhibit 135: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 136: Daiichi Sankyo Co. Ltd. - Key offerings
12.9 Eli Lilly and Co.
Exhibit 137: Eli Lilly and Co. - Overview
Exhibit 138: Eli Lilly and Co. - Product/Service
Exhibit 139: Eli Lilly and Co. - Key news
Exhibit 140: Eli Lilly and Co. - Key offerings
12.10 F. Hoffmann La Roche Ltd.
Exhibit 141: F. Hoffmann La Roche Ltd. - Overview
Exhibit 142: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 143: F. Hoffmann La Roche Ltd. - Key news
Exhibit 144: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 145: F. Hoffmann La Roche Ltd. - Segment focus
12.11 Fresenius Kabi AG
Exhibit 146: Fresenius Kabi AG - Overview
Exhibit 147: Fresenius Kabi AG - Business segments
Exhibit 148: Fresenius Kabi AG - Key news
Exhibit 149: Fresenius Kabi AG - Key offerings
Exhibit 150: Fresenius Kabi AG - Segment focus
12.12 Hikma Pharmaceuticals Plc
Exhibit 151: Hikma Pharmaceuticals Plc - Overview
Exhibit 152: Hikma Pharmaceuticals Plc - Business segments
Exhibit 153: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 154: Hikma Pharmaceuticals Plc - Segment focus
12.13 Novartis AG
Exhibit 155: Novartis AG - Overview
Exhibit 156: Novartis AG - Business segments
Exhibit 157: Novartis AG - Key offerings
Exhibit 158: Novartis AG - Segment focus
12.14 Otsuka Pharmaceutical Co. Ltd.
Exhibit 159: Otsuka Pharmaceutical Co. Ltd. - Overview
Exhibit 160: Otsuka Pharmaceutical Co. Ltd. - Product/Service
Exhibit 161: Otsuka Pharmaceutical Co. Ltd. - Key offerings
12.15 Sanofi SA
Exhibit 162: Sanofi SA - Overview
Exhibit 163: Sanofi SA - Business segments
Exhibit 164: Sanofi SA - Key news
Exhibit 165: Sanofi SA - Key offerings
Exhibit 166: Sanofi SA - Segment focus
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 167: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 168: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 169: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 170: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 171: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Viatris Inc.
Exhibit 172: Viatris Inc. - Overview
Exhibit 173: Viatris Inc. - Business segments
Exhibit 174: Viatris Inc. - Key news
Exhibit 175: Viatris Inc. - Key offerings
Exhibit 176: Viatris Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 177: Inclusions checklist
Exhibit 178: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 179: Currency conversion rates for US$
13.4 Research methodology
Exhibit 180: Research methodology
Exhibit 181: Validation techniques employed for market sizing
Exhibit 182: Information sources
13.5 List of abbreviations
Exhibit 183: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global antithrombotic drugs market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits 31: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Route of Administration
Exhibits 33: Data Table on Comparison by Route of Administration
Exhibits 34: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Oral - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Injectable - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Injectable - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Injectable - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Injectable - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Route of Administration ($ million)
Exhibits 43: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits 46: Chart on Comparison by Distribution Channel
Exhibits 47: Data Table on Comparison by Distribution Channel
Exhibits 48: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits 50: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits 51: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits 52: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits 54: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits 56: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits 58: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits 59: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits 60: Market opportunity by Distribution Channel ($ million)
Exhibits 61: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 65: Chart on Geographic comparison
Exhibits 66: Data Table on Geographic comparison
Exhibits 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 103: Market opportunity By Geographical Landscape ($ million)
Exhibits 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 105: Impact of drivers and challenges in 2022 and 2027
Exhibits 106: Overview on Criticality of inputs and Factors of differentiation
Exhibits 107: Overview on factors of disruption
Exhibits 108: Impact of key risks on business
Exhibits 109: Vendors covered
Exhibits 110: Matrix on vendor position and classification
Exhibits 111: Aspen Pharmacare Holdings Ltd - Overview
Exhibits 112: Aspen Pharmacare Holdings Ltd - Business segments
Exhibits 113: Aspen Pharmacare Holdings Ltd - Key offerings
Exhibits 114: Aspen Pharmacare Holdings Ltd - Segment focus
Exhibits 115: AstraZeneca PLC - Overview
Exhibits 116: AstraZeneca PLC - Product/Service
Exhibits 117: AstraZeneca PLC - Key news
Exhibits 118: AstraZeneca PLC - Key offerings
Exhibits 119: Bayer AG - Overview
Exhibits 120: Bayer AG - Business segments
Exhibits 121: Bayer AG - Key news
Exhibits 122: Bayer AG - Key offerings
Exhibits 123: Bayer AG - Segment focus
Exhibits 124: Boehringer Ingelheim International GmbH - Overview
Exhibits 125: Boehringer Ingelheim International GmbH - Business segments
Exhibits 126: Boehringer Ingelheim International GmbH - Key news
Exhibits 127: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 128: Boehringer Ingelheim International GmbH - Segment focus
Exhibits 129: Bristol Myers Squibb Co. - Overview
Exhibits 130: Bristol Myers Squibb Co. - Product/Service
Exhibits 131: Bristol Myers Squibb Co. - Key news
Exhibits 132: Bristol Myers Squibb Co. - Key offerings
Exhibits 133: Daiichi Sankyo Co. Ltd. - Overview
Exhibits 134: Daiichi Sankyo Co. Ltd. - Product/Service
Exhibits 135: Daiichi Sankyo Co. Ltd. - Key news
Exhibits 136: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits 137: Eli Lilly and Co. - Overview
Exhibits 138: Eli Lilly and Co. - Product/Service
Exhibits 139: Eli Lilly and Co. - Key news
Exhibits 140: Eli Lilly and Co. - Key offerings
Exhibits 141: F. Hoffmann La Roche Ltd. - Overview
Exhibits 142: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 143: F. Hoffmann La Roche Ltd. - Key news
Exhibits 144: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 145: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 146: Fresenius Kabi AG - Overview
Exhibits 147: Fresenius Kabi AG - Business segments
Exhibits 148: Fresenius Kabi AG - Key news
Exhibits 149: Fresenius Kabi AG - Key offerings
Exhibits 150: Fresenius Kabi AG - Segment focus
Exhibits 151: Hikma Pharmaceuticals Plc - Overview
Exhibits 152: Hikma Pharmaceuticals Plc - Business segments
Exhibits 153: Hikma Pharmaceuticals Plc - Key offerings
Exhibits 154: Hikma Pharmaceuticals Plc - Segment focus
Exhibits 155: Novartis AG - Overview
Exhibits 156: Novartis AG - Business segments
Exhibits 157: Novartis AG - Key offerings
Exhibits 158: Novartis AG - Segment focus
Exhibits 159: Otsuka Pharmaceutical Co. Ltd. - Overview
Exhibits 160: Otsuka Pharmaceutical Co. Ltd. - Product/Service
Exhibits 161: Otsuka Pharmaceutical Co. Ltd. - Key offerings
Exhibits 162: Sanofi SA - Overview
Exhibits 163: Sanofi SA - Business segments
Exhibits 164: Sanofi SA - Key news
Exhibits 165: Sanofi SA - Key offerings
Exhibits 166: Sanofi SA - Segment focus
Exhibits 167: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 168: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 169: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 170: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 171: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 172: Viatris Inc. - Overview
Exhibits 173: Viatris Inc. - Business segments
Exhibits 174: Viatris Inc. - Key news
Exhibits 175: Viatris Inc. - Key offerings
Exhibits 176: Viatris Inc. - Segment focus
Exhibits 177: Inclusions checklist
Exhibits 178: Exclusions checklist
Exhibits 179: Currency conversion rates for US$
Exhibits 180: Research methodology
Exhibits 181: Validation techniques employed for market sizing
Exhibits 182: Information sources
Exhibits 183: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global antithrombotic drugs market: AbbVie Inc., Aspen Pharmacare Holdings Ltd, AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Fresenius Kabi AG.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is advent of anticoagulant antidotes.'

According to the report, one of the major drivers for this market is the growing prevalence of coagulation disorders.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Aspen Pharmacare Holdings Ltd
  • AstraZeneca PLC
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • Hikma Pharmaceuticals Plc
  • Johnson and Johnson Services Inc.
  • Merck and Co. Inc.
  • Novartis AG
  • Otsuka Pharmaceutical Co. Ltd.
  • Pfizer Inc.
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Fresenius Kabi AG

Related Topics

Related Reports

Antithrombotic Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Antithrombotic Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 89 Pages
  • Global
From
Global Bronchiectasis Drugs Market 2023-2027 - Product Image

Global Bronchiectasis Drugs Market 2023-2027

  • Report
  • 168 Pages
  • Global
From
Global Motion Sickness Drugs Market 2023-2027 - Product Image

Global Motion Sickness Drugs Market 2023-2027

  • Report
  • 160 Pages
  • Global
From
Global Antiplatelet Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, and Injectable), By Drug Class, By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Global Antiplatelet Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, and Injectable), By Drug Class, By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • 312 Pages
  • Global
From
North America Antiplatelet Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, and Injectable), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Image

North America Antiplatelet Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, and Injectable), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • 128 Pages
  • North America
From

About the Antithrombotics Market

Antithrombotics are drugs used to prevent the formation of blood clots, which can lead to cardiovascular diseases such as stroke and heart attack. These drugs work by inhibiting the activity of clotting factors in the blood, thus preventing the formation of clots. Common antithrombotics include aspirin, clopidogrel, warfarin, and heparin. Aspirin is the most widely used antithrombotic, and is often prescribed to reduce the risk of stroke and heart attack. Clopidogrel is used to prevent blood clots in patients with coronary artery disease, while warfarin is used to prevent and treat blood clots in patients with atrial fibrillation. Heparin is used to prevent and treat deep vein thrombosis and pulmonary embolism. The antithrombotics market is highly competitive, with many large pharmaceutical companies offering a range of products. Some of the major players in the market include Bayer, Pfizer, Sanofi, Bristol-Myers Squibb, and Merck. These companies are continuously developing new products to meet the needs of patients and healthcare providers. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.